Los puntos clave no están disponibles para este artículo en este momento.
This Viewpoint reviews legalization initiatives for psychedelic substances and the concerns they raise by looking to the cautionary precedents involving the legalization and commercialization of other controlled substances.
Smith et al. (Mon,) studied this question.